Indefinite Delivery Contract HHSO100201500007I
Award Date 9/30/15
Last Date to Order 9/30/21
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
Pricing Type
Cost Plus Fixed Fee
Legislative Mandate
Clinger Cohen Act
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed Similar IDVs
- The Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response awarded a single-award, indefinite delivery/indefinite quantity contract valued up to $100 million to SRI International of Menlo Park, California. The contract aims to develop animal models for the Biomedical Advanced Research and Development Authority's countermeasure programs against radiological and nuclear threats. Under the contract, SRI International was issued a $309,727...
- The Office of the Assistant Secretary for Preparedness and Response (ASPR) awarded a $100 million Indefinite Delivery/Indefinite Quantity (IDIQ) contract to Lovelace Biomedical Research Institute, a not-for-profit preclinical contract research organization based in Albuquerque, New Mexico, for biological animal model development and medical countermeasure testing in support of the Biomedical Advanced Research and Development Authority's radiological and nuclear preparedness mission. The...
- The federal contract IDV award provides indefinite delivery of nonclinical biological services to the Department of Health and Human Services (HHS), specifically the Office of the Assistant Secretary for Preparedness and Response (ASPR). The purpose is to establish a network of Good Laboratory Practices (GLP) facilities capable of conducting animal testing and other analytical services to support the development of medical countermeasures against chemical, biological, radiological, and nuclear...
- The National Institute of Allergy and Infectious Diseases has awarded an Indefinite Delivery/Indefinite Quantity contract to Sri International to support medical countermeasure development efforts. Task orders issued to date involve animal model development, efficacy testing, and clinical safety studies for monoclonal antibodies, vaccines, and therapeutics against infectious disease targets. Work is conducted at Sri International's facility in West Menlo Park, California over periods ranging...
- This indefinite delivery contract with the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, aims to provide preclinical models of infectious diseases to support the development and evaluation of medical countermeasures. The single award contract, valued at up to $146.3 million, has a 7-year ordering period and covers three task areas: Task Area A - Small Animal Models of Infectious Diseases Task Area B - Non-Human Primate Models of Infectious Diseases Task Area C...
- The Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response awarded a single award indefinite delivery contract to Southern Research Institute located in Birmingham, Alabama. With a potential value of $100 million and a period of performance through September 2027, this contract aims to procure biological animal model and medical countermeasure development services in support of the Biomedical Advanced Research and Development Authority. A $4.68...
- This is an Indefinite Delivery Contract (IDC) awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency, to Lovelace Biomedical and Environmental Research Institute, Inc. (LBERI), a not-for-profit research organization. The contract has a ceiling value of $100,000,000 and a period of performance ending on September 30, 2021. The contract is for the development of animal models and medical countermeasures to support ASPR's Biological, Chemical, and...
- This Indefinite Delivery/Indefinite Quantity contract, awarded as a single award to Lovelace Biomedical Research Institute on July 28, 2022, supports the Biomedical Advanced Research and Development Authority's Chemical Readiness and Response Network animal model development program. The Office of the Assistant Secretary for Preparedness and Response, within the Department of Health and Human Services, established this civilian contract with a ceiling value of $45,000,000 and a completion date...
- This indefinite delivery contract (IDC) was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian federal agency, to Bioqual, Inc. as the prime contractor. The $146.3 million, single-award IDC has a 7-year period of performance and will support the development and refinement of animal and animal replacement models to evaluate candidate countermeasures (e.g. vaccines, therapeutics, diagnostics) against a range of infectious diseases, including those with...
- This indefinite delivery contract (IDC) was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to The Charles Stark Draper Laboratory, Inc. (Draper) for the development and employment of animal and animal replacement models of infectious diseases. The $146.3 million single-award IDC has a 7-year ordering period and supports the full range of preclinical evaluations, including screening, product evaluation, and eventual clinical evaluation of...
- BARDA Chem and RadNuc Animal Model 2015-2020Master IDIQ
- HHSO100201500007IIndefinite Delivery Contract
SRI INTERNATIONAL (RADNUC) - IDIQ FOR BARDA CRN ANIMAL MODEL DEVELOPMENT
Posted 9/30/15
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00006 | Other Administrative Action | $0 | 9/11/20 | |
| P00005 | Exercise an Option | $0 | 9/5/19 | |
| 4 | Exercise an Option | $0 | 9/25/18 | |
| 3 | Exercise an Option | $0 | 8/28/17 | |
| 2 | Other Administrative Action | $0 | 3/2/17 |
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
BARDA Chem and RadNuc Animal Model Development | RFP-15-100-SOL-00004 | Department of Health and Human Services Immediate Office of the Secretary | Award Notice 1/1 | 12/5/14, 11:42 AM |